DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,008 filers reported holding DANAHER CORPORATION in Q1 2022. The put-call ratio across all filers is 1.38 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $243,067 | +3.0% | 979,712 | -0.4% | 0.42% | +9.7% |
Q2 2023 | $236,090 | -8.3% | 983,708 | -3.7% | 0.38% | -14.8% |
Q1 2023 | $257,487 | -6.1% | 1,021,612 | -1.1% | 0.45% | -18.6% |
Q4 2022 | $274,289 | -99.9% | 1,033,416 | -12.5% | 0.55% | -11.2% |
Q3 2022 | $305,119,000 | -8.1% | 1,181,303 | -9.8% | 0.62% | +0.3% |
Q2 2022 | $331,937,000 | -15.5% | 1,309,311 | -2.2% | 0.62% | +17.3% |
Q1 2022 | $392,625,000 | -14.3% | 1,338,508 | -3.9% | 0.52% | -5.2% |
Q4 2021 | $458,059,000 | +0.9% | 1,392,233 | -6.6% | 0.55% | -0.7% |
Q3 2021 | $453,874,000 | +4.8% | 1,490,850 | -7.6% | 0.56% | +6.3% |
Q2 2021 | $433,066,000 | +31.8% | 1,613,751 | +10.6% | 0.52% | +23.5% |
Q1 2021 | $328,456,000 | +0.5% | 1,459,286 | -0.8% | 0.42% | -1.6% |
Q4 2020 | $326,811,000 | +0.8% | 1,471,196 | -2.3% | 0.43% | -8.5% |
Q3 2020 | $324,136,000 | +27.2% | 1,505,300 | +4.5% | 0.47% | +15.4% |
Q2 2020 | $254,779,000 | +5.9% | 1,440,813 | -17.1% | 0.41% | -17.4% |
Q1 2020 | $240,506,000 | -5.1% | 1,737,631 | +5.2% | 0.50% | +14.8% |
Q4 2019 | $253,402,000 | +38.4% | 1,651,040 | +30.2% | 0.43% | +22.1% |
Q3 2019 | $183,160,000 | -6.9% | 1,268,158 | -7.9% | 0.35% | -3.8% |
Q2 2019 | $196,813,000 | +19.3% | 1,377,085 | +10.2% | 0.37% | +13.3% |
Q1 2019 | $165,032,000 | +33.5% | 1,250,050 | +4.3% | 0.32% | +11.0% |
Q4 2018 | $123,592,000 | -5.1% | 1,198,525 | +0.0% | 0.29% | +14.5% |
Q3 2018 | $130,200,000 | +29.7% | 1,198,230 | +17.8% | 0.26% | +25.6% |
Q2 2018 | $100,404,000 | +6.4% | 1,017,475 | +5.6% | 0.20% | +1.5% |
Q1 2018 | $94,353,000 | +13.1% | 963,670 | +7.3% | 0.20% | +14.9% |
Q4 2017 | $83,398,000 | +17.8% | 898,487 | +8.9% | 0.17% | +13.0% |
Q3 2017 | $70,803,000 | +24.1% | 825,397 | +22.1% | 0.15% | +14.9% |
Q2 2017 | $57,043,000 | +611.7% | 675,945 | +751.8% | 0.13% | +509.1% |
Q2 2016 | $8,015,000 | -51.3% | 79,352 | -54.3% | 0.02% | -53.2% |
Q1 2016 | $16,454,000 | -42.5% | 173,457 | -43.7% | 0.05% | -42.0% |
Q4 2015 | $28,620,000 | +1.0% | 308,140 | -7.4% | 0.08% | -3.6% |
Q3 2015 | $28,343,000 | -12.0% | 332,626 | -11.6% | 0.08% | -4.5% |
Q2 2015 | $32,193,000 | -8.6% | 376,125 | -9.3% | 0.09% | -10.2% |
Q1 2015 | $35,214,000 | -11.9% | 414,764 | -11.1% | 0.10% | -11.7% |
Q4 2014 | $39,991,000 | +71.9% | 466,582 | +52.4% | 0.11% | +63.2% |
Q3 2014 | $23,259,000 | -5.5% | 306,118 | -2.1% | 0.07% | -2.9% |
Q2 2014 | $24,621,000 | +3.1% | 312,729 | -1.8% | 0.07% | +2.9% |
Q1 2014 | $23,884,000 | +2.5% | 318,449 | +5.5% | 0.07% | -2.9% |
Q4 2013 | $23,294,000 | +11.2% | 301,743 | -0.2% | 0.07% | +2.9% |
Q3 2013 | $20,957,000 | +5.4% | 302,327 | -3.8% | 0.07% | -4.2% |
Q2 2013 | $19,890,000 | – | 314,208 | – | 0.07% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |